Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Tectonic Therapeutic, Inc.AVRO · Entity 5328 | Chief Medical Officer | June 10, 2021 | June 14, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Tectonic Therapeutic, Inc.
Report date June 10, 2021 · Filed June 14, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.63 · Expires 2031-06-09 | Direct | 50,000 |
Reported balance
After 2021-06-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-06-10 · Grant · Acquired 50,000 · Balance 50,000 F1: 50% of the shares shall vest and become exercisable on June 10, 2023, and the remaining 50% shall vest and become exercisable on June 10, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: 50% of the shares shall vest and become exercisable on June 10, 2023, and the remaining 50% shall vest and become exercisable on June 10, 2024.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Viridian Therapeutics, Inc.\DE
Report date January 15, 2021 · Filed January 19, 2021
Section 16 reporting ended · disclosed 2021-01-19. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2021 Filed Jun 14, 2021 17:55 UTC | Tectonic Therapeutic, Inc. AVRO · Entity 5328 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $9.63 | $0.00 |
DisclosureSEC source: 0001127602-21-019832 · form4.xml · derivative · entry 1 Escolar Diana · CIK 0001797269 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-06-09 F1 · derivative.exercise_date: 50% of the shares shall vest and become exercisable on June 10, 2023, and the remaining 50% shall vest and become exercisable on June 10, 2024. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 16:55 UTC | Tectonic Therapeutic, Inc. AVRO · Entity 5328 | GrantStock Option (Right to Buy) · Derivative | 130,000 | $0.00 Strike: $14.55 | $0.00 |
DisclosureSEC source: 0001127602-21-003526 · form4.xml · derivative · entry 1 Escolar Diana · CIK 0001797269 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 130,000 shares Expires 2031-01-31 F1 · derivative.exercise_date: 25% of the shares shall vest and become exercisable on February 1, 2022, and the remaining 75% shall vest in equal monthly installments thereafter over a 3 year period. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 18:24 UTC | Viridian Therapeutics, Inc.\DE MGEN · Entity 4316 | GrantStock Option (right to buy) · Derivative | 270,000 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001209191-20-009789 · doc4.xml · derivative · entry 1 Escolar Diana · CIK 0001797269 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,000 Underlying: Common Stock · 270,000 shares Expires 2030-02-11 F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2016 Equity Incentive Plan (the "Plan"). The shares shall vest as follows: (i) 50% shall vest in 48 equal monthly installments beginning on March 12, 2020, (ii) 25% shall vest on completion of a specified milestone related to cobomarsen development and (iii) 25% shall vest on completion of a specified milestone related to MRG-229 development, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan. The shares underlying the option are subject to accelerated vesting upon the occurrence of specified events including a change of control of the Issuer and the Reporting Person's termination. The option expires ten years after the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.